HLA I immunopeptidome of synthetic long peptide pulsed human dendritic cells for therapeutic vaccine design
Synthetic long peptides (SLPs) are a promising vaccine modality that exploit dendritic cells (DC) to treat chronic infections or cancer. Currently,…
